Literature DB >> 127894

Effect of essential phospholipids on the properties of ATPases of isolated rat liver plasma membranes of young and old animals.

D Hegner, D Platt.   

Abstract

"Essential" phospholipids (EPL), rich in dilinoleyl-phosphatidylcholine were given orally to young and 780-800 day-old rats. The double-labelled (14C/32P) dilinoleyl-phosphatidylcholine was incorporated in plasma membranes and the amounts incorporated into different organs investigated. Old animals incorporated higher radioactivity than young. The 14C/32P ratio however decreased in comparison with the substance administered. The amount of (Na+-K+)-ATPase in rat liver plasma membranes of old animals increased after pretreatment with EPL. The thermostability of ATPases was increased in plasma membranes of EPL treated old animals. In old animals EPL significantly lowered the cholesterol content. The membrane fluidity increased. The role of EPl in structural and functional properties of aged plasma membranes is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 127894     DOI: 10.1016/0047-6374(75)90021-4

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  3 in total

1.  Effect of polyunsaturated phosphatidylcholine on immune mediated hepatocyte damage.

Authors:  J Neuberger; J E Hegarty; A L Eddleston; R Williams
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

2.  Prevention of immune dysfunction and vitamin E loss by dehydroepiandrosterone and melatonin supplementation during murine retrovirus infection.

Authors:  Z Zhang; M Araghi-Niknam; B Liang; P Inserra; S K Ardestani; S Jiang; S Chow; R R Watson
Journal:  Immunology       Date:  1999-02       Impact factor: 7.397

3.  Enhanced activity of hormone-sensitive adenylate cyclase during dietary restriction in the rat: dependence on age and relation to cell size.

Authors:  B Cooper; F Weinblatt; R I Gregerman
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.